Declan Doogan - Jun 9, 2022 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role: Director, 10%+ Owner
Signature: /s/ S. Halle Vakani, as Attorney-in-Fact
Stock symbol: TENX
Transactions as of: Jun 9, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/10/2022, 09:08 PM
Previous filing: Feb 11, 2022
Next filing: Aug 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TENX	Common Stock						3.07M	Jun 9, 2022	Direct	F1
holding	TENX	Common Stock						568K	Jun 9, 2022	By Declan Doogan 2021 GRAT DTD 03-04-2021	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TENX	Stock Option (right to buy)	Award	$0	+5K		$0.00	5K	Jun 9, 2022	Common Stock	5K	$0.62	Direct
holding	TENX	Stock Option (right to buy)						6.25K	Jun 9, 2022	Common Stock	6.25K	$2.00	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 11, 2021, the Reporting Person mistakenly filed a Form 4 reporting an aggregate beneficial ownership of 2,502,129, instead of 3,070,000 as reflected in the current filing.
F2	Dr. Doogan's wife, Dorothy Doogan, is the trustee of the Trust. Dr. Doogan disclaims beneficial ownership of the shares held by the Trust except to the extent of his pecuniary interest therein.